Anzeige
Mehr »
Login
Mittwoch, 06.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
416 Leser
Artikel bewerten:
(2)

IFS growth outperforms market in 2020 with 26% increase in software revenue

- 60% increase in Cloud revenue and 43% increase in recurring revenue YoY, despite macroeconomic backdrop

- Recurring revenue share now 80% of software revenue

- Service management license revenues increase by 105% YoY

LONDON, Jan. 28, 2021 /PRNewswire/ -- IFS, the global enterprise applications company, today announced its financial results for the full year ended December 31, 2020.

2020 saw widespread market disruption due to the Covid-19 pandemic. This has heightened the need for companies to build resilience into their business and adopt digital business models.

With this backdrop IFS has stood firm in its commitment to deliver measurable benefits to its customers and has doubled down on ensuring a faster time to value. This has been instrumental in delivering sustained growth in revenue and led to a 105-percent increase in Service Management revenue.

Some of the key milestones for IFS in 2020 included:

  • The acquisition of Clevest that has increased the depth of IFS's service management proposition
  • The launch of IFS Remote Assistance, that won Business Innovation of the Year at the Technology Excellence Awards
  • Growth in IFS's ecosystem, now with over 8,000 customers and partners having participated in paid-for and free training
  • The IFS Community growing to over 5,000 active contributors
  • The launch of the IFS Voice of the Customer program that has helped IFS achieve the highest customer satisfaction scores compared to industry peers (according to Gartner Peer Insights).

Throughout the year, IFS has continued to nurture its customer-first culture, strengthen its partner ecosystem and from a sustainability perspective, support the IFS Foundation, which is building a Technology Lab for Welasiya College in Puttalam District of Sri Lanka, a nation that is home to over 1,500 IFS employees.

IFS CEO Darren Roos commented: "I think that every CEO will have been affected one way or another by 2020. Like many, we had to adapt as individuals and as a business, but the passion this team has for customers continued to shine. I am hugely proud of that."

Roos continued, "I am also really proud to see that a sinificant part of our license revenue has come from new logos, customers who have moved away from their legacy vendor; this combined with our performance in recurring revenue points the performance of a very strong business. 2021 will be a hugely important year for IFS as we launch IFS Cloud on March 10th."

IFS Chief Financial Officer, Constance Minc, added, "This is the third consecutive year that IFS has delivered double digit growth, and over this period we have grown recurring revenue by 250%. This consistency, together with the improved revenue mix, reveals a strong business that continues to deliver with all the right ingredients to capitalize on our investment cycle. We have real strength in our service proposition, demonstarted by license revenue growing at 105 percent in 2020, as well as an industry focus in sectors like aerospace and defense that will ensure that we continue to deliver value to our customers."

Financial and Operational Highlights for FY 2020, growth YoY:

  • FY2020 software revenue was MSEK 5,092, an increase of 26 percent versus 2019
  • FY2020 recurring revenue was MSEK 4,081, an increase of 43 percent versus 2019
  • FY2020 cloud revenue increased 60 percent versus 2019
  • FY2020 net revenue was MSEK 7,211, an increase of 14 percent versus 2019
  • In addition, service business license revenue grew 105 percent versus 2019 while aerospace and defense license revenue grew 37 percent.

Additional highlights:

  • IFS added close to 200 new logos across its core industries, including Carlsberg, Panasonic, BRITA, LKAB, Savoye, Marshall Aerospace & Defence Group, MRO Logistics, Groupe Beneteau, Lely, De Havilland Aircraft Canada, Mitutoyo and Séché Environnement.
  • The partner Ecosystem grew 28 percent versus 2019 and participated in over 30 percent of implementations.
  • IFS held its leader status in the Gartner Magic Quadrant for Field Service Management, maintaining this position every year since 2014. Also in 2020 IFS was named a Leader in the IDC MarketScape for SaaS and Cloud- Enabled Large Enterprise ERP Applications, a Gartner Peer Insights Customer Choice Cloud ERP for Product-Centric Enterprises, a Gartner Peer Insights Customer Choice for EAM Applications and a Leader in the IDC MarketScape for SaaS and Cloud-Enabled EAM Applications.

*Note: all figures based in Swedish Krona and reported in constant currency.

Learn more at www.ifs.com/corp/company/financial-results/.

CONTACT:

Natalie Sutton
IFS Head of External Communications
Phone: +44 (0)1784 278222
press@ifs.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/ifs/r/ifs-growth-outperforms-market-in-2020-with-26--increase-in-software-revenue,c3274297

The following files are available for download:

https://news.cision.com/ifs/i/ifsfy20financialhighlights,c2871097

IFS FY20 financial highlights

© 2021 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.